Search results for: 'Logistics Industry In Malaysia'

Medicine production supply chains are currently operating under huge stress due to the war in Ukraine, COVID-19-related disruptions, logistics bottlenecks, and inflation. An energy-related shutdown of production would have a detrimental effect on the supply of critical medicines to patients in the EU and worldwide. The excessive amount of pressure ...

This study focuses on the top 10 strategic imperatives impacting the MedTech industry in 2025. The industry includes the medical devices and medical imaging and informatics markets. Top transformations impacting industry growth include competitive intensity, compression of the value chain, industry convergence, transformative megatrends, internal...

The impact of the digital revolution continues to disrupt the healthcare industry. This includes evolving digital technological capabilities, new business models and marketing approaches, the healthcare consumerism trend, the changing regulatory environment, and competitive threats from new market entrants, such as digital-native companies—particul...

The global medical imaging equipment and informatics industry is undergoing a structural transformation, driven by rising demand for diagnostic procedures, increasing prevalence of chronic diseases, and growing imaging volumes across care settings. The shift toward value-based care, coupled with the expansion of precision medicine, is accelerating ...

In 2024, the life science (LS) industry s focus on precision health will intensify. LS companies will augment their omics-based research capabilities and increasingly deploy AI and bioinformatics to discover personalized therapies. Partnerships between pharmaceutical companies and technology vendors will multiply, to support innovation in drug disc...

The pharmaceutical (pharma) industry is undergoing significant regulatory changes resulting from the European Green Deal and the Paris Agreement. These changes require pharma companies to adopt more environmentally sustainable practices. With the increasing demand for drugs globally, pharma R&D and manufacturing infrastructure has grown, leading to...

The global pharmaceutical market is projected to reach approximately $1.72 trillion in 2026, with large molecules driving most incremental growth while small molecules remain the sector’s cash flow base. The current growth cycle concentrates on cardiometabolic and oncology, led by GLP-1 platforms and antibody–drug conjugates (ADCs). Competitive adv...

In this analysis, Frost & Sullivan identifies and defines the leading trends shaping the global pharmaceutical landscape. The study period is 2022–2030, with 2024 as the base year and 2025–2028 as the forecast period. The geographic scope includes 5 regions: North America, Latin America (LATAM) and the Caribbean, Asia-Pacific (APAC), Europe, and th...

The insight analyzes the innovations expected to play a major role in shaping the global orthopedic devices industry over the next few years. The demand for patient-specific implantation/surgeries is rising, along with the demand for better procedural efficiencies. This is becoming a driver for the emergence of new technologies. Therapies and proce...